相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimizing the Method for Differentiation of Macrophages from Human Induced Pluripotent Stem Cells
Shanshan Li et al.
STEM CELLS INTERNATIONAL (2022)
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Eric Legius et al.
GENETICS IN MEDICINE (2021)
Modeling leukemia with pediatric acute leukemia patient-derived iPSCs
Ting Li et al.
STEM CELL RESEARCH (2021)
PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center
Yan Miao et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia
Tomonari Shigemura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Differentiation and Functional Comparison of Monocytes and Macrophages from hiPSCs with Peripheral Blood Derivatives
Xu Cao et al.
STEM CELL REPORTS (2019)
Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood
Haihui Gu et al.
STEM CELL RESEARCH & THERAPY (2018)
The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
Peter D. Stenson et al.
HUMAN GENETICS (2017)
Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function
Kazuyuki Takata et al.
IMMUNITY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only
D. G. Evans et al.
EBIOMEDICINE (2016)
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
Aurelie Caye et al.
NATURE GENETICS (2015)
Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia
Sonia Mulero-Navarro et al.
CELL REPORTS (2015)
Efficient Generation of Megakaryocytes From Human Induced Pluripotent Stem Cells Using Food and Drug Administration-Approved Pharmacological Reagents
Yanfeng Liu et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia
Tiffany Y. Chang et al.
BLOOD (2014)
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
Shilpa Gandre-Babbe et al.
BLOOD (2013)
Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML
M. Takagi et al.
LEUKEMIA (2013)
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi et al.
NATURE GENETICS (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis
A. Colley et al.
CLINICAL GENETICS (2010)
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1
Doris Steinemann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications
Oren N. Gottfried et al.
NEUROSURGICAL FOCUS (2010)
Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options
Charlotte Marie Niemeyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11
C. Flotho et al.
ONCOGENE (2007)
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies
Karen Stephens et al.
BLOOD (2006)
NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome
A De Luca et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Different mutations in the NF1 gene are associated with neurofibromatosis-Noonan syndrome (NFNS)
D Baralle et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor
K Cichowski et al.
GENES & DEVELOPMENT (2003)
分享论文
